Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cognitive rehabilitation for ME/CFS brain fog

Official title: Brain Training for Chronic, Post-viral, Brain Fog: Study A

Run by University of Alabama at Birmingham · NCT07523113 · Data updated 2026-11-12

Researchers are testing two cognitive rehabilitation approaches to see which helps adults with ME/CFS and brain fog better manage thinking and daily tasks.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedJune 23, 2026
Main results expectedJune 2027
Study endsJune 2028
Registry record updatedOctober 29, 2026
Trial IDNCT07523113 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with ME/CFS or post-viral fatigue who have mild or greater cognitive impairment and significant brain fog, able to travel for study visits and with reliable internet access.

Probably not a fit

Individuals without measurable cognitive impairment or those unable to participate in the in-person assessments may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two cognitive rehabilitation methods in adults with post-viral cognitive syndrome and ME/CFS. Participants undergo online testing at set intervals and have in-person visits for blood draws and brain imaging. The trial uses randomization to assign participants to Constraint-Induced Cognitive Therapy or another training approach, delivered largely via telehealth with some in-person assessments. Procedures include brief online assessments before and after treatment and a 6-month follow-up to gauge sustained effects. Key components include processing speed training, daily living activities training, a transfer package, follow-up calls, and optional trans-auricular vagus nerve stimulation at high intensity.

Why it matters

Potential benefit: If successful, participants may experience improved processing speed, cognitive function, and daily living ability.

How similar studies have gone: Similar cognitive rehabilitation approaches have shown signal in related fatigue and cognitive impairment populations, though this exact combination is relatively novel in ME/CFS.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of ME/CFS that preceded cognitive complaints
* mild or greater cognitive impairment
* moderate or greater brain fog
* some impairment in the performance of daily activities
* ≥ 18 years, no upper limit if medically stable
* reside in the community (as opposed to a hospital or skilled nursing facility)
* able to travel to the laboratory on multiple occasions
* has Internet service
* has a personal computer, laptop, or tablet that can access the Internet
* sufficiently fit, from both a physical and mental health perspective, to take part in the study
* adequate sight and hearing to complete the UFOV test
* adequate thinking skills, e.g., ability to follow directions and retain information to complete UFOV and CTAL, as marked by the judgement of the screener that the candidate is able to adequately complete the UFOV and CTAL
* sufficient English proficiency (i.e., ability to speak, understand, read, and write to take part in study activities)

Exclusion Criteria:

* cognitive impairment due to a developmental disability, psychiatric disorder, or substance abuse, or due to another type of brain injury, such as traumatic brain injury, stroke, or a progressive brain disease, such as Alzheimer's Dementia
* current substance abuse disorder
* diagnosis of postural orthostatic tachycardia syndrome (POTS) by a healthcare provider
* prior cognitive processing speed training on DoubleDecision or a similar program
* cannot tolerate taVNS
* prior history of heart attack or other serious cardiac events
* implanted medical device of any type
* vasovagal syncope or history of fainting
* history of seizures or epilepsy
* temporomandibular Joint (TMJ) syndrome or other conditions that cause substantial jaw pain
* history of peripheral nerve injury to the head, neck, or face
* pregnant or breastfeeding
* not able or willing to get an MRI scan
* not able or willing to get a blood draw

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

  • Principal investigator: Gitendra Uswatte, PhD — Professor of Psychology, University of Alabama at Birmingham
  • Study coordinator: Madeline Rathz, BS
  • Email: mgrathz@uab.edu
  • Phone: 205-934-9768

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.